trans-2-(1-(ethylsulfonyl)indolin-5-yl)-N-(piperidin-4-ylmethyl)cyclopropanamine

ID: ALA5183291

Chembl Id: CHEMBL5183291

PubChem CID: 168280874

Max Phase: Preclinical

Molecular Formula: C19H29N3O2S

Molecular Weight: 363.53

Names and Identifiers

Canonical SMILES:  CCS(=O)(=O)N1CCc2cc(C3CC3NCC3CCNCC3)ccc21

Standard InChI:  InChI=1S/C19H29N3O2S/c1-2-25(23,24)22-10-7-16-11-15(3-4-19(16)22)17-12-18(17)21-13-14-5-8-20-9-6-14/h3-4,11,14,17-18,20-21H,2,5-10,12-13H2,1H3

Standard InChI Key:  XXJFPDYHNSBYGX-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5183291

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 363.53

Molecular Weight (Monoisotopic): 363.1980

AlogP: 1.84

#Rotatable Bonds: 6

Polar Surface Area: 61.44

Molecular Species: BASE

HBA: 4

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 10.57

CX LogP: 1.02

CX LogD: -4.37

Aromatic Rings: 1

Heavy Atoms: 25

QED Weighted: 0.81

Np Likeness Score: -1.08

References

1. Li C, Su M, Zhu W, Kan W, Ge T, Xu G, Wang S, Sheng L, Gao F, Ye Y, Wang J, Zhou Y, Li J, Liu H..  (2022)  Structure-Activity Relationship Study of Indolin-5-yl-cyclopropanamine Derivatives as Selective Lysine Specific Demethylase 1 (LSD1) Inhibitors.,  65  (5.0): [PMID:35200034] [10.1021/acs.jmedchem.1c02156]

Source

Source(1):

• Scientific Literature